KK

Kanagasundaram Komalavalli

Active Director Director DIN 08718186
DIN 08718186 First appointment Mar 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Kanagasundaram Komalavalli

Data last updated:

Kanagasundaram Komalavalli is a Director at Mkm Pharma Private Limited (since 2020). The company operates in Pharma. Mkm Pharma Private Limited reported revenue of ₹22.39 Cr (FY 2025).

DIN 08718186
Primary Designation Director
Industry Pharma
First Appointment 06 Mar 2020
Oldest Company Age 6 yrs
Largest company Mkm Pharma Private Limited · ₹22.39 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mkm Pharma Private Limited U51909TZ2020PTC033549
Director06 Mar 20202020₹22.39 Cr (FY 2025)Active

Board colleagues of Kanagasundaram Komalavalli

NameDINCompanyDesignation
Kuppusamy Kathirvel08704185Mkm Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mkm Pharma Private Limited
Premium access

Shareholding and investment profile for Kanagasundaram Komalavalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanagasundaram Komalavalli

Kanagasundaram Komalavalli currently holds 1 directorship: Mkm Pharma Private Limited (Director, since 06 Mar 2020, revenue ₹22.39 Cr (FY 2025)).

Kanagasundaram Komalavalli was first appointed on 06 Mar 2020 as Director at Mkm Pharma Private Limited.

The current boards of Kanagasundaram Komalavalli's companies include Kuppusamy Kathirvel (Mkm Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available